Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled, Double-blind, Multi-center Clinical Study of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke

NCT04200781 is registered in ClinicalTrials.gov with ShuGuang Hospital as lead sponsor.

NCT NCT04200781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04200781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled, Double-blind, Multi-center Clinical Study of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
Lead sponsor
ShuGuang Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
September 1, 2019
Completion date
June 30, 2022
Enrollment
464 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhagic stroke